LN
Loulieta Nazerai
Rigshospitalet, Danish Cancer Society Research Center, University of Copenhagen
Research areas: Medicine · Oncology · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers · T-cell and B-cell Immunology
0000-0002-1090-9029
Employment
-
Rigshospitalet post doc2020 - Present
-
Danish Cancer Society Research Center2020 - Present
- ? - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach Save
- An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome Save
- Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma Save
- Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade Save
- Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain Save
- Functionally Competent, PD-1+ CD8+ Trm Cells Populate the Brain Following Local Antigen Encounter Save
- Effector CD8 T Cell-Dependent Zika Virus Control in the CNS Save
- A ‘Furry-Tale’ of Zika Virus Infection: What Have We Learned from Animal Models? Save
- Local Antigen Encounter Is Essential for Establishing Persistent CD8 + T-Cell Memory in the CNS Save
- A New In Vivo Model to Study Protective Immunity to Zika Virus Infection in Mice With Intact Type I Interferon Signaling Save
- Zika virus infection Save
- Early life vaccination Save
- PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A Save